[1] Zhao P, Wang C, Liu W, et al. Causes and outcomes of acute liver failure in China.PLoS One. 2013;8(11):e80991.
[2] Romero M, Palmer SL, Kahn JA, et al. Imaging appearance in acute liver failure: correlation with clinical and pathology findings. Dig Dis Sci. 2014;59(8):1987-1995.
[3] Willars C.Update in intensive care medicine: acute liver failure. Initial management, supportive treatment and who to transplant. Curr Opin Crit Care. 2014;20(2):202-209.
[4] Bernal W, Wendon J.Acute liver failure.N Engl J Med. 2013; 369(26):2525-2534.
[5] Wang DW, Yin YM, Yao YM.Advances in the management of acute liver failure.World J Gastroenterol. 2013;19(41): 7069-7077.
[6] Whitehouse T, Wendon J.Acute liver failure.Best Pract Res Clin Gastroenterol. 2013;27(5):757-769.
[7] Lee WM.Recent developments in acute liver failure.Best Pract Res Clin Gastroenterol. 2012;26(1):3-16.
[8] Lee WM.Acute liver failure.Semin Respir Crit Care Med. 2012;33(1):36-45.
[9] Canbay A, Tacke F, Hadem J, et al.Acute liver failure: a life-threatening disease.Dtsch Arztebl Int. 2011;108(42): 714-720.
[10] Sundaram V, Shaikh OS.Acute liver failure: current practice and recent advances.Gastroenterol Clin North Am. 2011; 40(3): 523-539.
[11] Chen SC, Mullon C, Kahaku E,et al.Treatment of severe liver failure with a bioartificial liver.Ann N Y Acad Sci. 1997;831: 350-360.
[12] Hoyer DP, Munteanu M, Canbay A,et al.Liver transplantation for acute liver failure: are there thresholds not to be crossed? Transpl Int. 2014;27(6):625-633.
[13] Rai R.Liver transplantatation- an overview.Indian J Surg. 2013; 75(3):185-191.
[14] Struecker B, Raschzok N, Sauer IM.Liver support strategies: cutting-edge technologies.Nat Rev Gastroenterol Hepatol. 2014;11(3):166-176.
[15] Bañares R, Catalina MV, Vaquero J.Liver support systems: will they ever reach prime time?Curr Gastroenterol Rep. 2013;15(3):312.
[16] Nevens F, Laleman W.Artificial liver support devices as treatment option for liver failure.Best Pract Res Clin Gastroenterol. 2012;26(1):17-26.
[17] Rozga J, Malkowski P.Artificial liver support: quo vadis.Ann Transplant. 2010;15(4):92-101.
[18] Kobashi-Margáin RA, Gavilanes-Espinar JG, Gutiérrez-Grobe Y, et al.Albumin dialysis with molecular adsorbent recirculating system (MARS) for the treatment of hepatic encephalopathy in liver failure.Ann Hepatol. 2011;10 Suppl 2:S70-76.
[19] Rademacher S, Oppert M, Jörres A.Artificial extracorporeal liver support therapy in patients with severe liver failure.Expert Rev Gastroenterol Hepatol. 2011;5(5):591-599.
[20] Yu Y, Fisher JE, Lillegard JB, et al. Cell therapies for liver diseases.Liver Transpl. 2012;18(1):9-21.
[21] Ohashi K.Liver tissue engineering: The future of liver therapeutics.Hepatol Res. 2008;38 Suppl 1:S76-87.
[22] Cusick RA, Lee H, Sano K,et al.The effect of donor and recipient age on engraftment of tissue-engineered liver.J Pediatr Surg. 1997;32(2):357-360.
[23] Török E, Pollok JM, Ma PX,et al.Hepatic tissue engineering on 3-dimensional biodegradable polymers within a pulsatile flow bioreactor.Dig Surg. 2001;18(3):196-203.
[24] Riccalton-Banks L, Liew C, Bhandari R,et al.Long-term culture of functional liver tissue: three-dimensional coculture of primary hepatocytes and stellate cells.Tissue Eng. 2003; 9(3):401-410.
[25] Ogawa K, Ochoa ER, Borenstein J,et al.The generation of functionally differentiated, three-dimensional hepatic tissue from two-dimensional sheets of progenitor small hepatocytes and nonparenchymal cells.Transplantation. 2004;77(12): 1783-1789.
[26] Sudo R, Mitaka T, Ikeda M,et al.Reconstruction of 3D stacked-up structures by rat small hepatocytes on microporous membranes.FASEB J. 2005;19(12):1695-1697.
[27] Soto-Gutierrez A, Navarro-Alvarez N, Rivas-Carrillo JD,et al.Construction and transplantation of an engineered hepatic tissue using a polyaminourethane-coated nonwoven polytetrafluoroethylene fabric.Transplantation. 2007;83(2): 129-137.
[28] Ohashi K, Yokoyama T, Yamato M,et al.Engineering functional two- and three-dimensional liver systems in vivo using hepatic tissue sheets.Nat Med. 2007;13(7):880-885.
[29] Turner WS, Schmelzer E, McClelland R,et al.Human hepatoblast phenotype maintained by hyaluronan hydrogels.J Biomed Mater Res B Appl Biomater. 2007;82(1):156-168.
[30] Underhill GH, Chen AA, Albrecht DR,et al.Assessment of hepatocellular function within PEG hydrogels.Biomaterials. 2007;28(2):256-270.
[31] Kadota Y, Yagi H, Inomata K,et al.Mesenchymal stem cells support hepatocyte function in engineered liver grafts. Organogenesis. 2014;10(2):268-277.
[32] Jiang WC, Cheng YH, Yen MH,et al.Cryo-chemical decellularization of the whole liver for mesenchymal stem cells-based functional hepatic tissue engineering.Biomaterials. 2014;35(11):3607-3617.
[33] Monsel A, Zhu YG, Gennai S,et al.Cell-based Therapy for Acute Organ Injury: Preclinical Evidence and Ongoing Clinical Trials Using Mesenchymal Stem Cells.Anesthesiology. 2014 Sep 10. [Epub ahead of print]
[34] V Volarevic V, Nurkovic J, Arsenijevic N,et al.Concise review: therapeutic potential of mesenchymal stem cells for the treatment of acute liver failure and cirrhosis.Stem Cells. 2014; 32(11):2818-2823.
[35] Esrefoglu M.Role of stem cells in repair of liver injury: experimental and clinical benefit of transferred stem cells on liver failure.World J Gastroenterol. 2013;19(40):6757-6773.
[36] Russo FP, Parola M.Stem cells in liver failure.Best Pract Res Clin Gastroenterol. 2012;26(1):35-45.
[37] Chistiakov DA.Liver regenerative medicine: advances and challenges.Cells Tissues Organs. 2012;196(4):291-312.
[38] Jiankang H, Dichen L, Yaxiong L,et al.Preparation of chitosan-gelatin hybrid scaffolds with well-organized microstructures for hepatic tissue engineering.Acta Biomater. 2009;5(1):453-461.
[39] Libera RD, Melo GB, Lima Ade S,et al.Assessment of the use of cryopreserved x freeze-dried amniotic membrane (AM) for reconstruction of ocular surface in rabbit model.Arq Bras Oftalmol. 2008;71(5):669-673. |